Concizumab (Anti-TFPI)
Product Specifications
CAS Number
1312299-39-0
Synonyms
NN 7415, mAb 2021, Anti-TFPI Recombinant Antibody
Additionnal Information
Concizumab (Anti-TFPI) is an anti-TFPI monoclonal antibody (IgG4 type) that binds to the Kunitz-type protease inhibitor (KPI) 2 structural domain of TFPI, thereby blocking the interaction of this structural domain with the FXa active site. MW : 145.5 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY420675 100 µg
HIG2 (HILPDA) (NM_001098786) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNCB2026-100 1x 100 µL
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
